Occult Brain Mets Detected in Patients With Advanced Renal Cancer
Asymptomatic brain metastases incidentally diagnosed in about 4% of patients with mRCC during clinical trial screening
Kidney Cancer
KIDNEY CANCER
VTE Risk High in Cancer Patients Receiving Immune Checkpoint Inhibitors
History of VTE predicts VTE occurrence; VTE occurrence linked to increased mortality
Local Salvage Therapy Effective for Local, Regional Recurrence of RCC
Local surgery or ablation may be most appropriate for patients with a solitary site of locoregional recurrence following definitive surgery for clinically localized renal cell carcinoma, according to investigators.
Pembrolizumab Plus Lenvatinib Prolongs Survival in Renal Cell Carcinoma
Investigators report findings from the phase 3 CLEAR trial that assessed outcomes with pembrolizumab plus lenvatinib, lenvatinib plus everolimus, or sunitinib in treatment-naive patients with advanced renal cell carcinoma.
Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
Cutaneous immune-related adverse events seen in 25% of cancer patients initiating ICI therapy with median onset time of 113 days
Renal Hypothermia During PN Fails to Preserve Kidney Function
A study of the effect of renal hypothermia during partial nephrectomy should have an immediate impact on surgical practice, according to investigators.
Prostate, Kidney, and Pancreas Surgery Utilization Rates Differ by Income
Study findings corroborate previous research linking higher income with increased healthcare utilization.
Factors Associated With Response to Nivolumab in Renal Cell Carcinoma
A study was conducted to assess factors contributing to response to nivolumab treatment for advanced clear cell renal cell carcinoma.
Obesity Tied to Increased Mortality Overall in Patients With Cancer, But Not RCC
Risk for death lower for patients with lung cancer, renal cell carcinoma, melanoma with versus without obesity
Fotivda Now Available for Renal Cell Carcinoma
Fotivda is an oral vascular endothelial growth factor tyrosine kinase inhibitor.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Kidney Cancer
